Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
25–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women with postmenopausal osteoporosis
You may not be if
Bilateral hip replacements
Esophageal abnormalities
Metabolic bone disease (example - Vitamin D deficiency)
Medications that would affect the breakdown or build-up of bone turnover
Clareo Health | A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
